EDGAR Filing Documents for 0001479290-17-000019

Form DEF 14A - Other definitive proxy statements:

SEC Accession No. 0001479290-17-000019

Filing Date

2017-03-24

Accepted

2017-03-24 16:58:27

Documents

Period of Report

2017-05-11

Effectiveness Date

2017-03-24

Document Format Files

Seq	Description	Document	Type	Size
1	DEF 14A	rvnc2017proxystatement.htm	DEF 14A	489077
2	GRAPHIC	dbsignature.jpg	GRAPHIC	3685
3	GRAPHIC	exercisenotice1a01.jpg	GRAPHIC	226349
4	GRAPHIC	exercisenotice2a01.jpg	GRAPHIC	380638
5	GRAPHIC	exercisenotice3a01.jpg	GRAPHIC	77893
6	GRAPHIC	exercisenotice4a01.jpg	GRAPHIC	29938
7	GRAPHIC	lssignature.jpg	GRAPHIC	4849
8	GRAPHIC	proxycard1a01.jpg	GRAPHIC	376613
9	GRAPHIC	proxycard2a01.jpg	GRAPHIC	379829
	Complete submission text file	0001479290-17-000019.txt		2528796

Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560

Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400

Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)